Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Molecular mechanisms underlying oligodendrocyte-immune cell interactions in neuroinflammation

FY 2022-23

Summary
Canada has one of the highest global rates of multiple sclerosis (MS) with an estimated 90,000 people living with this disease across the country. In MS, the immune system attacks myelin-producing cells known as oligodendrocytes. Myelin acts as a protective covering for cells found in the brain and spinal cord, namely neurons. However, when myelin is damaged, neurons become impaired and function improperly, leading to neurological disability. Despite the devastating number of people battling MS, the underlying cause remains unknown and there are currently no treatments to protect oligodendrocytes, partly due to a lack of understanding of what causes oligodendrocyte injury in MS. Therefore, my project will investigate the interaction between oligodendrocytes and a type of immune cell called T cells by specifically looking at a molecule found on the surface of oligodendrocytes: intracellular adhesion molecule 1 (ICAM-1). This will be achieved by utilizing mature human oligodendrocytes derived from neurosurgery in collaboration with Dr. Antel (McGill), as well as a mouse model of MS known as experimental autoimmune encephalomyelitis, to study the role of ICAM-1 in modulating oligodendrocyte-T cell interactions. The goal of my project is to establish the potential of ICAM-1 as a novel therapeutic target to reduce oligodendrocyte damage caused by immune cells in MS. Protecting oligodendrocytes from damage would promote regrowth of myelin, therefore limiting the progression of MS. My project will additionally contribute to understanding the exact cause of MS, which is pivotal for reducing and limiting the immense personal, social, and economic burdens that accompany those living with MS.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486411
Name
Krysak Megan A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Molecular mechanisms underlying oligodendrocyte-immune cell interactions in neuroinflammation
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Experimental Autoimmune Encephalomyelitis; Multiple Sclerosis; Myelin; Oligodendrocytes; T Cells
Abstract
Canada has one of the highest global rates of multiple sclerosis (MS) with an estimated 90,000 people living with this disease across the country. In MS, the immune system attacks myelin-producing cells known as oligodendrocytes. Myelin acts as a protective covering for cells found in the brain and spinal cord, namely neurons. However, when myelin is damaged, neurons become impaired and function improperly, leading to neurological disability. Despite the devastating number of people battling MS, the underlying cause remains unknown and there are currently no treatments to protect oligodendrocytes, partly due to a lack of understanding of what causes oligodendrocyte injury in MS. Therefore, my project will investigate the interaction between oligodendrocytes and a type of immune cell called T cells by specifically looking at a molecule found on the surface of oligodendrocytes: intracellular adhesion molecule 1 (ICAM-1). This will be achieved by utilizing mature human oligodendrocytes derived from neurosurgery in collaboration with Dr. Antel (McGill), as well as a mouse model of MS known as experimental autoimmune encephalomyelitis, to study the role of ICAM-1 in modulating oligodendrocyte-T cell interactions. The goal of my project is to establish the potential of ICAM-1 as a novel therapeutic target to reduce oligodendrocyte damage caused by immune cells in MS. Protecting oligodendrocytes from damage would promote regrowth of myelin, therefore limiting the progression of MS. My project will additionally contribute to understanding the exact cause of MS, which is pivotal for reducing and limiting the immense personal, social, and economic burdens that accompany those living with MS.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Krysak, Megan A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~